On Monday, New York Times hit an important technical milestone, with its Relative Strength (RS) Rating entering into the 80-plus percentile with an upgrade to 82, up from 79 the day before.
IBD's unique rating identifies share price movement with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over the last 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains tend to have an 80 or higher RS Rating as they launch their biggest climbs.
Hone Your Stock-Picking Skills By Focusing On These Factors
While it's not currently an ideal time to jump in, see if the stock is able to establish and enter a buying range in heavy trade.
While earnings growth fell in the company's most recently reported quarter from 63% to 18%, revenue grew 7%, up from 6% in the previous report. Keep an eye out for the company's next round of numbers on or around Nov. 4.
New York Times holds the No. 1 rank among its peers in the Media-Newspapers industry group. New York Times and News Corp Cl A are also among the group's highest-rated stocks.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
